menu

Pleural Effusions Treatment Market

Schedule Call

Pleural Effusions Treatment Market

Pleural Effusions Treatment Market by Disease Type (Transudative, Exudative), Treatment (Quantitative Test Chest Draining, Pleurodesis), End User (Hospitals, Ambulatory Clinics, Other End Users) – Global Outlook & Forecast 2023-2031

GR - 716949 Category: Medical Devices

Number of pages: 100  |  Report Format: PDF  |  Published date: May 23, 2023

Historical Years – 2021  |  Base Year – 2022  |  Forecasted Years – 2023 to 2031


Pleural Effusions Treatment Market Scope

Report Attribute

Details

Market Size Value in 2022

US$ 4.67 billion

Revenue Forecast in 2031

US$ 8.10 billion

CAGR

6.3%

Base Year For Estimation

2022

Forecast Period

2023 to 2031

Historical Year

2021

Segments Covered

Disease Type, Treatment, End User, and Region

Regional Scope

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Report Overview

According to the deep-dive market assessment study by Growth Plus Reports, the global pleural effusions treatment market was valued at US$ 4.67 billion in 2022 and is expected to register a revenue CAGR of 6.3% to reach US$ 8.10 billion by 2031.

Pleural Effusions Treatment Market Fundamentals

Pleural effusion, commonly referred to as water on the lungs, is when too much fluid accumulates between the pleura layers surrounding the lungs. The lining of the chest cavity and lungs, known as the pleura, is made up of thin membranes that improve lubrication and assist breathing. A small quantity of fluid is normally present in these membranes. However, when the amount surpasses the usual value, pleural effusion occurs and has to be medically treated. The severity of a pleural effusion depends on a number of variables, including its source, if breathing is blocked, and whether it is treatable. Suppose heart failure, pneumonia, or a virus are to blame for the effusion. In that case, the underlying condition can be treated or under control.

Pleural effusion is a challenging medical illness since individuals do not exhibit any outward symptoms, and the problem is first discovered via a chest x-ray taken for any other reason. However, the most common symptoms, which might be unrelated or connected depending on the origin of the effusion, are dyspnea, orthopnea, a dry or nonproductive cough, and chest discomfort. According to the National Cancer Center, pleural effusions are exceedingly prevalent and afflict more than 1 million people in the U.S. each year.

The research study on the pleural effusions treatment market overview thoroughly analyzes the market, along with the aspects that either help or hinder the market's growth, such as its drivers, challenges, and opportunities. The research also discusses the list of businesses that operate in this market and their efforts to establish themselves as major players through expansion plans and innovative ideas. It also emphasizes current events that support the market's revenue expansion. 

This report is an important tool for the industry stakeholders to gather all the information about the market, customers, and competition. The report also provides the readers with valuable insights on the segmentation, regions, market size & forecast, revenue CAGRs, and other valuable data to help make informed strategic decisions. The study compiles information gathered from industry participants and specialists across the industry value chain. The report also taps into the qualitative and quantitative assessments by industry analysts. Our reports use different methods for estimating the market size and forecast, including secondary research, surveys and interviews, and statistical modeling. With these steps, our reports provide the most accurate market data. These datasets will cumulatively provide in-depth Pleural Effusions Treatment market forecast to the industry stakeholders.

 

Pleural Effusions Treatment Market Dynamics 

Pleural effusions are becoming more common, and there has been tremendous improvement in managing them internationally, which is projected to benefit market growth. Pleural effusions (PE) are becoming more common, one of the main drivers of market expansion. For instance, according to a WebMD LLC article from October 2021, there are 1.5 million pleural effusion diagnoses each year in the United States, and 320 instances of pleural effusion are thought to occur for every 100,000 persons in developed nations. Due to the severity of the ailment, there is a global need for pleural effusion therapies. Additionally, it is anticipated to drive market expansion during the study period.

The expansion of accurate illness diagnoses may raise the worldwide market's size. Pleural effusions are so frequent that practically all medical professionals advise getting tested even when getting checked out for other issues. Patients with systemic lupus erythematosus frequently see Pleural effusions. Pleural effusions harm more than 25% to 45% of systemic lupus erythematosus patients. Growing illness awareness may support the expansion of the world market.

Pleural Effusions Treatment Market Ecosystem

Pleural Effusions Treatment Market, by Disease Type

  • Transudative
  • Exudative

Pleural Effusions Treatment Market, by Treatment

  • Quantitative Test Chest Draining
  • Pleurodesis
  • Thoracentesis
  •  Pleuroperitoneal shunt
  • Catheter
  • Others

Pleural Effusions Treatment Market, by End User

  • Hospitals
  • Ambulatory Clinics
  • Other End Users

Pleural Effusions Treatment Market by Disease Type

The transudative pleural effusions segment shows lucrative growth during the forecast period. Fluid from a transudative pleural effusion (TPE) resembles the fluid one typically has in their pleural area. It develops as a result of fluids seeping through the typical pleura. Unless it is quite huge, this kind seldom has to be emptied. In affluent nations, congestive heart failure (CHF) accounts for most transudative pleural effusions and is the most frequent cause. Thus, the segment is projected to expand throughout the projection period due to the rising CHF incidence.

When the systemic parameters affecting the pleural fluid's production or absorption are changed, a transudative pleural effusion results. The basic pathogenic process does not affect the surfaces of the pleura. By analyzing the pleural fluid's properties, transudative effusion may be easily diagnosed. Refractory symptomatic transudative pleural effusions indicate pleural drainage, according to the paper "Randomized trial of indwelling pleural catheters for refractory transudative pleural effusions" published in February 2022. Additionally, evidence from observation supports the use of indwelling pleural catheters (IPCs) to treat transudative effusions. Such TPE-related research is projected to stimulate demand for novel treatments supporting the segment's expansion.

Segmentation of the market refers to the division of the industry into subgroups based on factors such as disease type, treatment, end user and region etc. Market segmentation data helps businesses to understand the preferences and unique needs of different customer groups and develop targeted sales strategies. This information also helps in identifying potential Pleural Effusions Treatment market growth opportunities. 

Pleural Effusions Treatment Market by Region

Over the projection period, North America is expected to grow and keep dominating the market. Due to growing healthcare costs, more research and development, and a rise in the frequency of cardiac illnesses, the United States dominates the market among other nations in the area. Additionally, the market for pleural effusions is primarily driven by the growing elderly population in the United States. Pleural effusions are frequently malignant in patients with cancer and heart failure. The market for pleural effusions is anticipated to benefit from the rising illness burden in the U.S. According to data from the American Cancer Society's Cancer Statistics 2022, there will likely be 1.9 million new instances of cancer identified in the U.S. that year.

In addition, the aging population in the United States has made heart failure an increasing health and financial burden. Nearly 115 million Americans have hypertension, 100 million are obese, 92 million have prediabetes, 26 million have diabetes, and 125 million have atherosclerotic cardiovascular diseases (CVD), which are known to be risk factors for the development of heart failure. These statistics came from the American Heart Association and were updated in April 2022. Therefore, the target population in the United States is at risk for pleural effusions due to the high prevalence of cardiovascular disorders. This is anticipated to stimulate market the expansion.

Due to an increase in lung cancer cases and respiratory conditions, the Asia Pacific pleural effusion treatment market is expected to grow significantly, with a revenue CAGR of 6.6%. The Asia Pacific region now has more access to a variety of pleural effusion treatments because of developments in healthcare technologies.

Based on the regions, the global pleural effusions treatment market is segmented into:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • United Kingdom
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific 
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Regional demarcation of the industry will provide information on geographic pockets regarding the pleural effusions treatment market outlook, size, share, and growth rate. This data helps businesses evaluate the expansion potential into new regional markets, understand the competitive threats across different regions, and develop localized sales and expansion strategies. 

Key Components of the Report 

  • In-depth review of the prevalent market trends
  • Annualized market size and forecast of every segment across 5 regions and 14 countries from 2021 to 2031.
  • Market-specific analysis of the segments on a global level and further elaboration of trends in each region and country
  • Competitive landscape of key players in the global market, based on market share or competitive positioning.
  • Profiles of major market players based on the business landscape, financial growth, and depth of product portfolio.

Pleural Effusions Treatment Market Competitive Landscape 

  • B. Braun SE,
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche Ltd.
  • Bicakcilar
  • Grena
  • Redax
  • Biometrix
  • Rocket Medical
  • Cook Medical
  • Smith Medical

The market competitive landscape is performed by collecting and analyzing information about the key competitors, the present industry trends, and market dynamics. It includes information collection and analysis on factors such as products, pricing, geographic outreach, customer demographics, marketing strategies, and recent developments. Competitive landscape assessment will help businesses identify the current prevalent or potential opportunities and threats keeping in mind the pleural effusions treatment industry trends. 

Pleural Effusions Treatment Market Strategic Developments

  • In April 2022, Malignant Pleural Effusion was the subject of a research named "IFN-Combined with T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites" that was filed with ClinicalTrials.gov.
  • In May 2021, the FDA authorized the first-of-its-kind targeted treatment for lung cancer mutations that was previously regarded as medication resistant. The treatment, known as Lumakras (sotorasib), will be used for adult patients with non-small cell lung cancer, provided that the patient has taken at least one systemic therapy and the tumor carries the genetic mutation known as KRAS G12C.
  • In September 2021, the CheckMate -743 trial's three-year data was released by Bristol Mayer Squibb. According to clinical study data, 54% of patients taking OPDIVO with YERVOY experienced significant side effects. Pneumonia, pyrexia, diarrhea, pneumonitis, pleural effusion, dyspnea, acute renal damage, infusion-related response, musculoskeletal discomfort, and pulmonary embolism were the most common significant side effects recorded in 2% of patients.

Key Strengths of Our Report 

  • Forecast till 2031
  • Cross-sectional Coverage Across 14 Countries
  • Consumer Level Segmentation
  • Regulatory Landscape
  • Key Cross Competition
  • Unmet Needs
  • Market Attractiveness
  • Analysis of Pipeline Prospects
  • Market Drivers and Challenges

Target Audience to Benefit from this Report.

  • New entrants to the market, start-ups, investors, and equity firms
  • Manufacturers, distributors, developers, and regulators of products. 
  • Research and consulting firms
  • Associations and governmental bodies 
  • Business associations, forums, lobbying groups, and reporting organizations

Reasons to Buy this Report

  • Detailed analysis of the impact of the COVID-19 pandemic on the global pleural effusions treatment market
  • Develop your growth strategies by reviewing the prevalent market trends, innovations, segment analysis, regional market landscape, and future opportunities.
  • Information on relevant laws and regulations that impact the market, such as product safety standards or import/export regulations.
  • Understanding the market's future competitive landscape and providing an insightful analysis of the major industry drivers and obstacles.
  • Identify the competitive landscape of the global market and understand the intensity of competition. 
  • Finding established and promising new competitors in the market will aid in creating competitive advantage tactics.
  • Track the revenue growth of the global, regional, and country-level markets and make effective expansion decisions.
  • Strategize sales and marketing goals by determining the most premium opportunities in the colorectal cancer screening market.
  • Evaluate potential return on investment for new products or services by analyzing CAGR data, businesses can evaluate the potential return on investment.
  • Our robust sources and research methodologies deliver accurate market sizing and forecast, which are further validated by authentic primary sources, including CMOs from major market players and key opinion leaders.

Frequently Asked Questions About This Report

Pleural effusion, commonly referred to as water on the lungs, is when too much fluid accumulates between the pleura layers surrounding the lungs.

The total Pleural Effusions Treatment market size worldwide in 2022 will be US$ 4.67 billion.

The North America region will have the largest pleural effusions treatment market size during the forecast period from 2023 to 2031.

The revenue CAGR in the global pleural effusions treatment market is expected to be 6.3%.

The resultant market size of the pleural effusions treatment market in 2031 will be US$ 8.10 billion.

Advancements in understanding the disease provide growth opportunities in the global pleural effusions treatment market.

The discomfort associated with treatments is the key challenges hamper the growth of the global pleural effusions treatment market.

Some of the prominent market players in the global market include B. Braun SE, Becton, Dickinson and Company, and F. Hoffmann-La Roche Ltd.

The transudative segment has the highest share in the global pleural effusions treatment market.

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
  3. PREMIUM INSIGHTS
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2022)
    3. Regulatory Landscape
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
  5. GLOBAL PLEURAL EFFUSIONS TREATMENT MARKET - ANALYSIS & FORECAST, BY DISEASE TYPE
    1. Transudative
    2. Exudative
  6. GLOBAL PLEURAL EFFUSIONS TREATMENT MARKET - ANALYSIS & FORECAST, BY TREATMENT
    1. Quantitative Test Chest Draining
    2. Pleurodesis
    3. Thoracentesis
    4.  Pleuroperitoneal shunt
    5. Catheter
    6. Others            
  7. GLOBAL PLEURAL EFFUSIONS TREATMENT MARKET - ANALYSIS & FORECAST, BY END USER
    1. Hospitals
    2. Ambulatory Clinics
    3. Other End Users
  8. GLOBAL PLEURAL EFFUSIONS TREATMENT MARKET - ANALYSIS & FORECAST, BY REGION
    1. North America Pleural Effusions Treatment Market
      1. North America Pleural Effusions Treatment Market, by Disease Type
      2. North America Pleural Effusions Treatment Market, by Treatment
      3. North America Pleural Effusions Treatment Market, by End User
      4. North America Pleural Effusions Treatment Market, by Country
        1. U.S.
          1. U.S. Pleural Effusions Treatment Market, by Disease Type 
          2. U.S. Pleural Effusions Treatment Market, by Treatment
          3. U.S. Pleural Effusions Treatment Market, by End User
        2. Canada
          1. Canada Pleural Effusions Treatment Market, by Disease Type 
          2. Canada Pleural Effusions Treatment Market, by Treatment
          3. Canada Pleural Effusions Treatment Market, by End User
    2. Europe Pleural Effusions Treatment Market
      1. Europe Pleural Effusions Treatment Market, by Disease Type 
      2. Europe Pleural Effusions Treatment Market, by Treatment 
      3. Europe Pleural Effusions Treatment Market, by End User
      4. Europe Pleural Effusions Treatment Market, by Country/Region
        1. Germany
          1. Germany Pleural Effusions Treatment Market, by Disease Type 
          2. Germany Pleural Effusions Treatment Market, by Treatment
          3. Germany Pleural Effusions Treatment Market, by End User 
        2. U.K.
          1. U.K. Pleural Effusions Treatment Market, by Disease Type 
          2. U.K. Pleural Effusions Treatment Market, by Treatment
          3. U.K. Pleural Effusions Treatment Market, by End User 
        3. France
          1. France Pleural Effusions Treatment Market, by Disease Type 
          2. France Pleural Effusions Treatment Market, by Treatment
          3. France Pleural Effusions Treatment Market, by End User
        4. Spain
          1. Spain Pleural Effusions Treatment Market, by Disease Type 
          2. Spain Pleural Effusions Treatment Market, by Treatment
          3. Spain Pleural Effusions Treatment Market, by End User 
        5. Italy
          1. Italy Pleural Effusions Treatment Market, by Disease Type 
          2. Italy Pleural Effusions Treatment Market, by Treatment
          3. Italy Pleural Effusions Treatment Market, by End User 
        6. Rest of Europe 
          1. Rest of Europe Pleural Effusions Treatment Market, by Disease Type 
          2. Rest of Europe Pleural Effusions Treatment Market, by Treatment
          3. Rest of Europe Pleural Effusions Treatment Market, by End User 
    3. Asia Pacific Pleural Effusions Treatment Market
      1. Asia Pacific Pleural Effusions Treatment Market, by Disease Type 
      2. Asia Pacific Pleural Effusions Treatment Market, by Treatment
      3. Asia Pacific Pleural Effusions Treatment Market, by End User
      4. Asia Pacific Pleural Effusions Treatment Market, by Country/Region
        1. China
          1. China Pleural Effusions Treatment Market, by Disease Type 
          2. China Pleural Effusions Treatment Market, by Treatment
          3. China Pleural Effusions Treatment Market, by End User 
        2. Japan
          1. Japan Pleural Effusions Treatment Market, by Disease Type 
          2. Japan Pleural Effusions Treatment Market, by Treatment 
          3. Japan Pleural Effusions Treatment Market, by End User
        3. India
          1. India Pleural Effusions Treatment Market, by Disease Type 
          2. India Pleural Effusions Treatment Market, by Treatment
          3. India Pleural Effusions Treatment Market, by End User 
        4. South Korea
          1. South Korea Pleural Effusions Treatment Market, by Disease Type 
          2. South Korea Pleural Effusions Treatment Market, by Treatment
          3. South Korea Pleural Effusions Treatment Market, by End User
        5. Australia
          1. Australia Pleural Effusions Treatment Market, by Disease Type 
          2. Australia Pleural Effusions Treatment Market, by Treatment
          3. Australia Pleural Effusions Treatment Market, by End User 
        6. Rest of Asia Pacific
          1. Rest of Asia Pacific Pleural Effusions Treatment Market, by Disease Type 
          2. Rest of Asia Pacific Pleural Effusions Treatment Market, by Treatment
          3. Rest of Asia Pacific Pleural Effusions Treatment Market, by End User 
    4. Latin America Pleural Effusions Treatment Market
      1. Latin America Pleural Effusions Treatment Market, by Disease Type 
      2. Latin America Pleural Effusions Treatment Market, by Treatment
      3. Latin America Pleural Effusions Treatment Market, by End User 
      4. Latin America Pleural Effusions Treatment Market, by Country/ Region
        1. Brazil
          1. Brazil Pleural Effusions Treatment Market, by Disease Type 
          2. Brazil Pleural Effusions Treatment Market, by Treatment
          3. Brazil Pleural Effusions Treatment Market, by End User 
        2. Mexico
          1. Mexico Pleural Effusions Treatment Market, by Disease Type 
          2. Mexico Pleural Effusions Treatment Market, by Treatment 
          3. Mexico Pleural Effusions Treatment Market, by End User
        3. Argentina
          1. Argentina Pleural Effusions Treatment Market, by Disease Type 
          2. Argentina Pleural Effusions Treatment Market, by Treatment
          3. Argentina Pleural Effusions Treatment Market, by End User 
        4. Rest of Latin America
          1. Rest of Latin America Pleural Effusions Treatment Market, by Disease Type 
          2. Rest of Latin America Pleural Effusions Treatment Market, by Treatment 
          3. Rest of Latin America Pleural Effusions Treatment Market, by End User
    5. Middle East & Africa Pleural Effusions Treatment Market
      1. Middle East & Africa Pleural Effusions Treatment Market, by Disease Type 
      2. Middle East & Africa Pleural Effusions Treatment Market, by Treatment
      3. Middle East & Africa Pleural Effusions Treatment Market, by End User 
      4. Middle East & Africa a Pleural Effusions Treatment Market, by Country/ Region
        1. GCC Countries
          1. GCC Countries Pleural Effusions Treatment Market, by Disease Type 
          2. GCC Countries Pleural Effusions Treatment Market, by Treatment
          3. GCC Countries Pleural Effusions Treatment Market, by End User 
        2. South Africa
          1. South Africa Pleural Effusions Treatment Market, by Disease Type 
          2. South Africa Pleural Effusions Treatment Market, by Treatment 
          3. South Africa Pleural Effusions Treatment Market, by End User
        3. Rest of Middle East & Africa
          1. Rest of Middle East & Africa Pleural Effusions Treatment Market, by Disease Type 
          2. Rest of Middle East & Africa Pleural Effusions Treatment Market, by Treatment
          3. Rest of Middle East & Africa Pleural Effusions Treatment Market, by End User 
  9. COMPANY PROFILES         
    1. B. Braun SE
      1. Business Snapshot 
      2. Products Offered
      3. Financial Details
      4. Strategic Development
    2. Becton, Dickinson and Company
    3. F. Hoffmann-La Roche Ltd
    4. Bicakcilar
    5. Grena
    6. Redax
    7. Biometrix
    8. Rocket Medical
    9. Cook Medical
    10. Smith Medical

*Insights on financial performance are subject to the availability of information in the public domain

List of Tables

  1. Global Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million)
  2. Global Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  3. Global Pleural Effusions Treatment Market, by End User, 2021–2031 (US$ Million) 
  4. Global Pleural Effusions Treatment Market, by Region, 2021-2031 (US$ Million) 
  5. North America Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million) 
  6. North America Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  7. North America Pleural Effusions Treatment Market, by End User, 2021–2031 (US$ Million) 
  8. North America Pleural Effusions Treatment Market, by Country, 2021-2031 (US$ Million)
  9. U.S. Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million) 
  10. U.S. Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  11. U.S. Pleural Effusions Treatment Market, by End User, 2021–2031 (US$ Million) 
  12. Canada Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million) 
  13. Canada Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  14. Canada Pleural Effusions Treatment Market, by End User, 2021–2031 (US$ Million) 
  15. Europe Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million) 
  16. Europe Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  17. Europe Pleural Effusions Treatment Market, by End User, 2021–2031 (US$ Million) 
  18. Europe Pleural Effusions Treatment Market, by Country/ Region, 2021-2031 (US$ Million) 
  19. Germany Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million) 
  20. Germany Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  21. Germany Pleural Effusions Treatment Market, by End User, 2021–2031 (US$ Million)
  22. U.K. Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million) 
  23. U.K. Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  24. U.K. Pleural Effusions Treatment Market, by End User, 2021–2031 (US$ Million
  25. France Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million) 
  26. France Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  27. France Pleural Effusions Treatment Market, by End User, 2021–2031 (US$ Million) 
  28. Italy Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million) 
  29. Italy Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  30. Italy Pleural Effusions Treatment Market, by End User, 2021–2031 (US$ Million) 
  31. Spain Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million) 
  32. Spain Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  33. Spain Pleural Effusions Treatment Market, by End User, 2021–2031 (US$ Million) 
  34. Rest of Europe Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million) 
  35. Rest of Europe Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  36. Rest of Europe Pleural Effusions Treatment Market, by End User, 2021–2031 (US$ Million) 
  37. Asia Pacific Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million) 
  38. Asia Pacific Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  39. Asia Pacific Pleural Effusions Treatment Market, by End User, 2021–2031 (US$ Million) 
  40. Asia Pacific Pleural Effusions Treatment Market, by Country/ Region, 2021-2031 (US$ Million) 
  41. China Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million) 
  42. China Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  43. China Pleural Effusions Treatment Market, by End User, 2021–2031 (US$ Million) 
  44. Japan Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million) 
  45. Japan Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  46. Japan Pleural Effusions Treatment Market, by End User, 2021–2031 (US$ Million) 
  47. India Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million) 
  48. India Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  49. India Pleural Effusions Treatment Market, by End User, 2021–2031 (US$ Million) 
  50. South Korea Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million) 
  51. South Korea Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  52. South Korea Pleural Effusions Treatment Market, by End User, 2021–2031 (US$ Million) 
  53. Australia Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million) 
  54. Australia Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  55. Australia Pleural Effusions Treatment Market, by End User, 2021–2031 (US$ Million) 
  56. Rest of Asia Pacific Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million) 
  57. Rest of Asia Pacific Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  58. Rest of Asia Pacific Pleural Effusions Treatment Market, by End User, 2021–2031 (US$ Million)
  59. Latin America Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million) 
  60. Latin America Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  61. Latin America Pleural Effusions Treatment Market, by End User, 2021–2031 (US$ Million) 
  62. Latin America Pleural Effusions Treatment Market, by Country/ Region, 2021–2031 (US$ Million)
  63. Brazil Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million) 
  64. Brazil Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  65. Brazil Pleural Effusions Treatment Market, by End User, 2021–2031 (US$ Million) 
  66. Mexico Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million) 
  67. Mexico Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  68. Mexico Pleural Effusions Treatment Market, by End User, 2021–2031 (US$ Million) 
  69. Argentina Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million) 
  70. Argentina Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  71. Argentina Pleural Effusions Treatment Market, by End User, 2021–2031 (US$ Million) 
  72. Rest of Latin America Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million) 
  73. Rest of Latin America Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  74. Rest of Latin America Pleural Effusions Treatment Market, by End User, 2021–2031 (US$ Million)
  75. Middle East and Africa Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million) 
  76. Middle East and Africa Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  77. Middle East and Africa Pleural Effusions Treatment Market, by End User 2021–2031 (US$ Million)
  78. Middle East and Africa Pleural Effusions Treatment Market, by Country/ Region, 2021–2031 (US$ Million)
  79. GCC Countries Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million) 
  80. GCC Countries Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  81. GCC Countries Pleural Effusions Treatment Market, by End User, 2021–2031 (US$ Million) 
  82. South Africa Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million) 
  83. South Africa Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  84. South Africa Pleural Effusions Treatment Market, by End User, 2021–2031 (US$ Million) 
  85. Rest of Middle East & Africa Pleural Effusions Treatment Market, by Disease Type, 2021-2031 (US$ Million) 
  86. Rest of Middle East & Africa Pleural Effusions Treatment Market, by Treatment, 2021–2031 (US$ Million) 
  87. Rest of Middle East & Africa Pleural Effusions Treatment Market, by End User, 2021–2031 (US$ Million)

List of Figures

  1. Pleural Effusions Treatment Market Ecosystem  
  2. Snapshot of Global Pleural Effusions Treatment Market, 2021-2031 
  3. Snapshot of Global Pleural Effusions Treatment Market, by Region, 2021-2031 
  4. Global Pleural Effusions Treatment Market: COVID-19 Pandemic Impact Assessment 
  5. Global Pleural Effusions Treatment Market: Key Players & Competitive Positioning (2021) 
  6. Pleural Effusions Treatment: Market Dynamics 
  7. Global Pleural Effusions Treatment Market for Transudative, 2021-2031 (US$ Million) 
  8. Global Pleural Effusions Treatment Market for Exudative, 2021-2031 (US$ Million) 
  9. Global Pleural Effusions Treatment Market for Quantitative Test Chest Draining, 2021-2031 (US$ Million) 
  10. Global Pleural Effusions Treatment Market for Thoracentesis, 2021-2031 (US$ Million) 
  11. Global Pleural Effusions Treatment Market for Pleuroperitoneal shunt, 2021-2031 (US$ Million) 
  12. Global Pleural Effusions Treatment Market for Catheter, 2021-2031 (US$ Million) 
  13. Global Pleural Effusions Treatment Market for Others, 2021-2031 (US$ Million) 
  14. Global Pleural Effusions Treatment Market for Hospitals, 2021-2031 (US$ Million) 
  15. Global Pleural Effusions Treatment Market for Ambulatory Clinics, 2021-2031 (US$ Million) 
  16. Global Pleural Effusions Treatment Market for Others,2021-2031 (US$ Million)
  17. North America Pleural Effusions Treatment Market, 2021-2031 (US$ Million) 
  18. U.S. Pleural Effusions Treatment Market, 2021-2031 (US$ Million) 
  19. Canada Pleural Effusions Treatment Market, 2021-2031 (US$ Million) 
  20. Europe Pleural Effusions Treatment Market, 2021-2031 (US$ Million) 
  21. Germany Pleural Effusions Treatment Market, 2021-2031 (US$ Million) 
  22. U.K. Pleural Effusions Treatment Market, 2021-2031 (US$ Million) 
  23. France Pleural Effusions Treatment Market, 2021-2031 (US$ Million) 
  24. Italy Pleural Effusions Treatment Market, 2021-2031 (US$ Million) 
  25. Spain Pleural Effusions Treatment Market, 2021-2031 (US$ Million) 
  26. Rest of Europe Pleural Effusions Treatment Market, 2021-2031 (US$ Million) 
  27. Asia Pacific Pleural Effusions Treatment Market, 2021-2031 (US$ Million) 
  28. China Pleural Effusions Treatment Market, 2021-2031 (US$ Million) 
  29. Japan Pleural Effusions Treatment Market, 2021-2031 (US$ Million) 
  30. India Pleural Effusions Treatment Market, 2021-2031 (US$ Million) 
  31. South Korea Pleural Effusions Treatment Market, 2021-2031 (US$ Million) 
  32. Australia Pleural Effusions Treatment Market, 2021-2031 (US$ Million) 
  33. Rest of Asia Pacific Pleural Effusions Treatment Market, 2021-2031 (US$ Million) 
  34. Latin America Pleural Effusions Treatment Market, 2021-2031 (US$ Million) 
  35. Brazil Pleural Effusions Treatment Market, 2021-2031 (US$ Million) 
  36. Mexico Pleural Effusions Treatment Market, 2021-2031 (US$ Million) 
  37. Argentina Pleural Effusions Treatment Market, 2021-2031 (US$ Million)
  38. Rest of Latin America Pleural Effusions Treatment Market, 2021-2031 (US$ Million)
  39. Middle East & Africa Pleural Effusions Treatment Market, 2021-2031 (US$ Million) 
  40. GCC Countries Pleural Effusions Treatment Market, 2021-2031 (US$ Million) 
  41. South Africa Pleural Effusions Treatment Market, 2021-2031 (US$ Million) 
  42. Rest of Middle East & Africa Pleural Effusions Treatment Market, 2021-2031 (US$ Million)
  43. B. Braun SE Revenue from 2019 Onwards (US$ Million)
  44. Becton, Dickinson and Company Revenue from 2019 Onwards (US$ Million)
  45. F. Hoffmann-La Roche Ltd. Revenue from 2019 Onwards (US$ Million)
  46. Bicakcilar Revenue from 2019 Onwards (US$ Million)
  47. Grena Revenue from 2019 Onwards (US$ Million)
  48. Redax Revenue from 2019 Onwards (US$ Million)
  49. Biometrix Revenue from 2019 Onwards (US$ Million)
  50. Rocket Medical Revenue from 2019 Onwards (US$ Million)
  51. Cook Medical Revenue from 2019 Onwards (US$ Million)
  52. Smith Medical Revenue from 2019 Onwards (US$ Million)

Single User License
Single User License
Multi User License
Enterprise User License
$4,750.00
Provides access to one user only and should not be shared with other employees within the organization.
Provides access to up to five users within the department or an organization.
Provides access to all the employees in the organization. The report can also be shared with subsidiaries, sister concerns and group entities.
Grants user/users’ access to quantitative data only, which includes but is not restricted to numeric data, tables, and charts as defined by Growth+ Reports.
  • What are the significant driving and restraining factors for the Pleural Effusions Treatment Market?
  • Who are the leading companies in the market?
  • Where can you find the updates on recent developments by market players?
  • When is the right time to get discounts on complete market reports?
  • Why to invest in the Pleural Effusions Treatment Market?
  • How to improve your organizational performance?
  • How to shift customers towards your brand?

Recommended Reports